Cargando…

Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease

BACKGROUND: Parkinson's disease is a common neurodegenerative disease characterised by progressive loss of dopaminergic neurons, leading to dopamine depletion in the striatum. Mutations in the PINK1 gene cause an autosomal recessive form of Parkinson's disease. Loss of PINK1 function cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Sonia, Vaarmann, Annika, Yao, Zhi, Duchen, Michael R., Wood, Nicholas W., Abramov, Andrey Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360782/
https://www.ncbi.nlm.nih.gov/pubmed/22662171
http://dx.doi.org/10.1371/journal.pone.0037564
_version_ 1782234053211062272
author Gandhi, Sonia
Vaarmann, Annika
Yao, Zhi
Duchen, Michael R.
Wood, Nicholas W.
Abramov, Andrey Y.
author_facet Gandhi, Sonia
Vaarmann, Annika
Yao, Zhi
Duchen, Michael R.
Wood, Nicholas W.
Abramov, Andrey Y.
author_sort Gandhi, Sonia
collection PubMed
description BACKGROUND: Parkinson's disease is a common neurodegenerative disease characterised by progressive loss of dopaminergic neurons, leading to dopamine depletion in the striatum. Mutations in the PINK1 gene cause an autosomal recessive form of Parkinson's disease. Loss of PINK1 function causes mitochondrial dysfunction, increased reactive oxygen species production and calcium dysregulation, which increases susceptibility to neuronal death in Parkinson's disease. The basis of neuronal vulnerability to dopamine in Parkinson's disease is not well understood. METHODOLOGY: We investigated the mechanism of dopamine induced cell death in transgenic PINK1 knockout mouse neurons. We show that dopamine results in mitochondrial depolarisation caused by mitochondrial permeability transition pore (mPTP) opening. Dopamine-induced mPTP opening is dependent on a complex of reactive oxygen species production and calcium signalling. Dopamine-induced mPTP opening, and dopamine-induced cell death, could be prevented by inhibition of reactive oxygen species production, by provision of respiratory chain substrates, and by alteration in calcium signalling. CONCLUSIONS: These data demonstrate the mechanism of dopamine toxicity in PINK1 deficient neurons, and suggest potential therapeutic strategies for neuroprotection in Parkinson's disease.
format Online
Article
Text
id pubmed-3360782
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33607822012-06-01 Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease Gandhi, Sonia Vaarmann, Annika Yao, Zhi Duchen, Michael R. Wood, Nicholas W. Abramov, Andrey Y. PLoS One Research Article BACKGROUND: Parkinson's disease is a common neurodegenerative disease characterised by progressive loss of dopaminergic neurons, leading to dopamine depletion in the striatum. Mutations in the PINK1 gene cause an autosomal recessive form of Parkinson's disease. Loss of PINK1 function causes mitochondrial dysfunction, increased reactive oxygen species production and calcium dysregulation, which increases susceptibility to neuronal death in Parkinson's disease. The basis of neuronal vulnerability to dopamine in Parkinson's disease is not well understood. METHODOLOGY: We investigated the mechanism of dopamine induced cell death in transgenic PINK1 knockout mouse neurons. We show that dopamine results in mitochondrial depolarisation caused by mitochondrial permeability transition pore (mPTP) opening. Dopamine-induced mPTP opening is dependent on a complex of reactive oxygen species production and calcium signalling. Dopamine-induced mPTP opening, and dopamine-induced cell death, could be prevented by inhibition of reactive oxygen species production, by provision of respiratory chain substrates, and by alteration in calcium signalling. CONCLUSIONS: These data demonstrate the mechanism of dopamine toxicity in PINK1 deficient neurons, and suggest potential therapeutic strategies for neuroprotection in Parkinson's disease. Public Library of Science 2012-05-25 /pmc/articles/PMC3360782/ /pubmed/22662171 http://dx.doi.org/10.1371/journal.pone.0037564 Text en Gandhi et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Gandhi, Sonia
Vaarmann, Annika
Yao, Zhi
Duchen, Michael R.
Wood, Nicholas W.
Abramov, Andrey Y.
Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
title Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
title_full Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
title_fullStr Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
title_full_unstemmed Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
title_short Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
title_sort dopamine induced neurodegeneration in a pink1 model of parkinson's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360782/
https://www.ncbi.nlm.nih.gov/pubmed/22662171
http://dx.doi.org/10.1371/journal.pone.0037564
work_keys_str_mv AT gandhisonia dopamineinducedneurodegenerationinapink1modelofparkinsonsdisease
AT vaarmannannika dopamineinducedneurodegenerationinapink1modelofparkinsonsdisease
AT yaozhi dopamineinducedneurodegenerationinapink1modelofparkinsonsdisease
AT duchenmichaelr dopamineinducedneurodegenerationinapink1modelofparkinsonsdisease
AT woodnicholasw dopamineinducedneurodegenerationinapink1modelofparkinsonsdisease
AT abramovandreyy dopamineinducedneurodegenerationinapink1modelofparkinsonsdisease